| 产品描述: | bPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs. |
| 参考文献: |
1. Thomas E Wooters, et al. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. Br J Pharmacol. 2011, 163,2. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.723 ml |
8.616 ml |
17.232 ml |
| 5 mM |
0.345 ml |
1.723 ml |
3.446 ml |
| 10 mM |
0.172 ml |
0.862 ml |
1.723 ml |
| 50 mM |
0.034 ml |
0.172 ml |
0.345 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |